Table 4 Anti-inflammatory and immune-regulatory effects related differentially expressed genes and their FPKM
No. | Gene ID | Gene Name | Protein Annotation | Group | FPKM | |||||
|---|---|---|---|---|---|---|---|---|---|---|
Before administration / High dose | After administration / Low dose | |||||||||
1 | MSTRG.13790 | LOC108351137 | Glyceraldehyde-3-phosphate dehydrogenase, GAPDH | AA VS AT10 | 1221.52 | 1284.88 | 1228.59 | 0 | 0 | 0 |
AA VS AT01 | 1221.52 | 1284.88 | 1228.59 | 0 | 0 | 0 | ||||
AT10 VS AT1 | 0 | 0 | 0 | 1166.15 | 1257.69 | 1155.12 | ||||
AT1 VS AT01 | 1166.15 | 1257.69 | 1155.12 | 0 | 0 | 0 | ||||
2 | MSTRG.2701 | GPX3 | Glutathione peroxidase 3, GPX3 | AA VS AA01 | 118.24 | 211.05 | 129.51 | 378.47 | 320.96 | 304.55 |
3 | MSTRG.4849 | SRSF9 | Serine/arginine-rich splicing factor-9, SRSF9 | AA VS AT1 | 14.19 | 15.7 | 15.56 | 33.01 | 35.53 | 30.19 |
4 | MSTRG.121 | CTGF | Connective tissue growth factor, CTGF | AA VS AT10 | 703.83 | 755.68 | 623.55 | 190.01 | 716.87 | 141.59 |
5 | MSTRG.10440 | CSTB | Cystatin B, CSTB | AA VS AT01 | 180.14 | 180.15 | 185.93 | 75.93 | 80.14 | 190.53 |
AT1 VS AT01 | 187.17 | 187.48 | 174.88 | 75.93 | 80.14 | 190.53 | ||||